Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data

CONCLUSION: A high number of concurrent medications was associated with poor clinical outcomes.PMID:38600328 | PMC:PMC11006739 | DOI:10.1007/s00432-024-05728-z

Source: Clinical Lung Cancer - April 10, 2024 Category: Cancer & Oncology Authors: Soojung Hong Ju Hyun Lee Ja Yoon Heo Koung Jin Suh Se Hyun Kim Yu Jung Kim Jee Hyun Kim Source Type: research